Catherine Matthes

Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

CuriMeta, Inc. collaborates with health systems and academic medical centers to transform and curate real-world health data for researchers to gain insights and solve scientific and clinical challenges. CuriMeta is led by highly experienced industry veterans and is based in St. Louis, MO. The company is committed to improving patient outcomes across all therapeutic areas and being a trusted strategic partner. The company was founded by Davis Walp, who has been the CEO since incorporation.

Euphrates Vascular, Inc. provides medical devices. It offers treatment addressing vascular occlusions related to vascular disease. The company is headquartered in St. Louis, MO.

Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO.